Overview
Actuated Medical's NeuralGlider(r) Precision Brain Access Platform has been scientifically validated by more than 40 preclinical neuroscience research groups worldwide and cited in over 44 peer-reviewed publications. Actuated is now optimizing NeuralGlider for clinical applications to improve access to deep brain targets while reducing tissue disruption in delicate brain structures. The company is partnering with organizations seeking to improve the insertion precision of neuromodulation systems, gene therapies, brain-computer interfaces, and other next-generation neurotechnologies.
More in Neurotechnology
Latest industry news
Noninvasive Brain Interface Uses AI Suggestions to Triple Communication Speed
2026-11-21 · Research
Zhongke Borui Closes $15M Round to Scale Brain-Computer Interface Hardware in China
2026-11-20 · Funding
ALS Community Gains a Formal Voice in Brain-Computer Interface Development
2026-11-19 · Policy
Science Corporation Closes $400M Round to Push Brain-Computer Interface Technology Into the Clinic
2026-11-18 · Funding
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →